Topical acyclovir formulations and uses thereof
US11246872B2 · kind B2 · utility
0Cited by
13References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 12, 2020 |
| Grant date | Feb 15, 2022 |
| Priority date | — |
| Expiry date | Jun 12, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are gel formulations of acyclovir with a low concentration of acyclovir, which can be used, for example, for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adults and adolescents 12 years of age and older. The gel formulation can be an aqueous gel formulation, an emulsified gel formulation, or a non-aqueous gel formulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.